Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT01784861. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
ClinicalTrials.gov study NCT02421939. IPD Sharing: YES. Countries: 14. Publications: 4.
p38 Mitogen-Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma
ClinicalTrials.gov study NCT00676572. IPD Sharing: NO. Countries: 1. Publications: 1.
ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia
ClinicalTrials.gov study NCT02029443. IPD Sharing: YES. Countries: 3. Publications: 8.
The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mut
ClinicalTrials.gov study NCT04179890. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency
ClinicalTrials.gov study NCT02476916. IPD Sharing: NO. Countries: 6. Publications: 3.
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
ClinicalTrials.gov study NCT00604383. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II S
ClinicalTrials.gov study NCT01229150. IPD Sharing: NO. Countries: 1. Publications: 4.
A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
ClinicalTrials.gov study NCT00585195. IPD Sharing: NO. Countries: 4. Publications: 18.
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT02944617. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01871805. IPD Sharing: Not stated. Countries: 2. Publications: 7.
Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00424632. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients
ClinicalTrials.gov study NCT01520519. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
ClinicalTrials.gov study NCT00932451. IPD Sharing: Not stated. Countries: 22. Publications: 7.
A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection
ClinicalTrials.gov study NCT01832259. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor
ClinicalTrials.gov study NCT02426086. IPD Sharing: Not stated. Countries: 11. Publications: 1.
(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
ClinicalTrials.gov study NCT03580655. IPD Sharing: Not stated. Countries: 12. Publications: 3.
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706
ClinicalTrials.gov study NCT03655236. IPD Sharing: NO. Countries: 6. Publications: 1.
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Ref
ClinicalTrials.gov study NCT04240002. IPD Sharing: NO. Countries: 5. Publications: 1.
A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)
ClinicalTrials.gov study NCT03474679. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.